145 related articles for article (PubMed ID: 7550027)
1. In vivo imaging and specific targeting of P-glycoprotein expression in multidrug resistant nude mice xenografts with [125I]MRK-16 monoclonal antibody.
Scott AM; Rosa E; Mehta BM; Divgi CR; Finn RD; Biedler JL; Tsuruo T; Kalaigian H; Larson SM
Nucl Med Biol; 1995 May; 22(4):497-504. PubMed ID: 7550027
[TBL] [Abstract][Full Text] [Related]
2. Measurement of P-glycoprotein expression in human neuroblastoma xenografts using in vitro quantitative autoradiography.
Fonti R; Levchenko A; Mehta BM; Zhang J; Tsuruo T; Larson SM
Nucl Med Biol; 1999 Jan; 26(1):35-41. PubMed ID: 10096499
[TBL] [Abstract][Full Text] [Related]
3. Enhancement by recombinant human interferon alfa of the reversal of multidrug resistance by MRK-16 monoclonal antibody.
Fogler WE; Pearson JW; Volker K; Ariyoshi K; Watabe H; Riggs CW; Wiltrout RH; Longo DL
J Natl Cancer Inst; 1995 Jan; 87(2):94-104. PubMed ID: 7707396
[TBL] [Abstract][Full Text] [Related]
4. In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB/c nude mice.
Clarke K; Lee FT; Brechbiel MW; Smyth FE; Old LJ; Scott AM
Cancer Res; 2000 Sep; 60(17):4804-11. PubMed ID: 10987290
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of carbon-14-colchicine biodistribution with whole-body quantitative autoradiography in colchicine-sensitive and -resistant xenografts.
Mehta BM; Levchenko A; Rosa E; Kim SW; Winnick S; Zhang JJ; Kalaigian H; Larson SM
J Nucl Med; 1996 Feb; 37(2):312-4. PubMed ID: 8667068
[TBL] [Abstract][Full Text] [Related]
6. Regression of established tumors expressing P-glycoprotein by combinations of adriamycin, cyclosporin derivatives, and MRK-16 antibodies.
Watanabe T; Naito M; Kokubu N; Tsuruo T
J Natl Cancer Inst; 1997 Apr; 89(7):512-8. PubMed ID: 9086008
[TBL] [Abstract][Full Text] [Related]
7. Reversal of drug resistance in a human colon cancer xenograft expressing MDR1 complementary DNA by in vivo administration of MRK-16 monoclonal antibody.
Pearson JW; Fogler WE; Volker K; Usui N; Goldenberg SK; Gruys E; Riggs CW; Komschlies K; Wiltrout RH; Tsuruo T
J Natl Cancer Inst; 1991 Oct; 83(19):1386-91. PubMed ID: 1681110
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of cellular accumulation of cyclosporine by anti-P-glycoprotein monoclonal antibody MRK-16 and synergistic modulation of multidrug resistance.
Naito M; Tsuge H; Kuroko C; Koyama T; Tomida A; Tatsuta T; Heike Y; Tsuruo T
J Natl Cancer Inst; 1993 Feb; 85(4):311-6. PubMed ID: 7678867
[TBL] [Abstract][Full Text] [Related]
9. In vivo uptake of carbon-14-colchicine for identification of tumor multidrug resistance.
Mehta BM; Rosa E; Biedler JL; Larson SM
J Nucl Med; 1994 Jul; 35(7):1179-84. PubMed ID: 8014680
[TBL] [Abstract][Full Text] [Related]
10. Tumor-specific accumulation of 125I-labeled mouse-human chimeric anti-CEA antibody in a xenografted human cancer model demonstrated by whole-body autoradiography and immunostaining.
Haruno M; Kuroki M; Matsunaga K; Takata J; Karube Y; Senba T; Murakami M; Arakawa F; Kuwahara M; Ozaki H; Matsuoka Y; Okazaki M; Kanda H
Nucl Med Biol; 1996 Aug; 23(6):821-6. PubMed ID: 8940726
[TBL] [Abstract][Full Text] [Related]
11. Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts.
Lee FT; Rigopoulos A; Hall C; Clarke K; Cody SH; Smyth FE; Liu Z; Brechbiel MW; Hanai N; Nice EC; Catimel B; Burgess AW; Welt S; Ritter G; Old LJ; Scott AM
Cancer Res; 2001 Jun; 61(11):4474-82. PubMed ID: 11389078
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of 11C-colchicine for PET imaging of multiple drug resistance.
Levchenko A; Mehta BM; Lee JB; Humm JL; Augensen F; Squire O; Kothari PJ; Finn RD; Leonard EF; Larson SM
J Nucl Med; 2000 Mar; 41(3):493-501. PubMed ID: 10716325
[TBL] [Abstract][Full Text] [Related]
13. Differences between the catabolism and tumour distribution of intact monoclonal antibody (791T/36) and its Fab/c fragment in mice with tumour xenografts revealed by the use of a residualizing radiolabel (dilactitol-125I-tyramine) and autoradiography.
Demignot S; Pimm MV; Thorpe SR; Baldwin RW
Cancer Immunol Immunother; 1991; 33(6):359-66. PubMed ID: 1878889
[TBL] [Abstract][Full Text] [Related]
14. Rapid and specific targeting of monoclonal antibody A33 to a colon cancer xenograft in nude mice.
Barendswaard EC; Scott AM; Divgi CR; Williams C; Coplan K; Riedel E; Yao TJ; Gansow OA; Finn RD; Larson SM; Old LJ; Welt S
Int J Oncol; 1998 Jan; 12(1):45-53. PubMed ID: 9454885
[TBL] [Abstract][Full Text] [Related]
15. Combined therapy with anti-P-glycoprotein antibody and macrophage colony-stimulating factor gene transduction for multiorgan metastases of multidrug-resistant human small cell lung cancer in NK cell-depleted SCID mice.
Yano S; Hanibuchi M; Nishioka Y; Nokihara H; Nishimura N; Tsuruo T; Sone S
Int J Cancer; 1999 Jul; 82(1):105-11. PubMed ID: 10360828
[TBL] [Abstract][Full Text] [Related]
16. Incidence of P-glycoprotein overexpression and multidrug resistance (MDR) reversal in adult soft tissue sarcoma.
Coley HM; Verrill MW; Gregson SE; Odell DE; Fisher C; Judson IR
Eur J Cancer; 2000 May; 36(7):881-8. PubMed ID: 10785593
[TBL] [Abstract][Full Text] [Related]
17. Tumor imaging by antineuroblastoma monoclonal antibody and its application to treatment.
Etoh T; Takahashi H; Maie M; Ohnuma N; Tanabe M
Cancer; 1988 Oct; 62(7):1282-6. PubMed ID: 3416269
[TBL] [Abstract][Full Text] [Related]
18. Specific targeting and killing activities of anti-P-glycoprotein monoclonal antibody MRK16 directed against intrinsically multidrug-resistant human colorectal carcinoma cell lines in the nude mouse model.
Iwahashi T; Okochi E; Ariyoshi K; Watabe H; Amann E; Mori S; Tsuruo T; Ono K
Cancer Res; 1993 Nov; 53(22):5475-82. PubMed ID: 8106147
[TBL] [Abstract][Full Text] [Related]
19. A new mdr-1 encoded P-170 specific monoclonal antibody: (6/1C) on paraffin wax embedded tissue without pretreatment of sections.
Moran E; Larkin A; Doherty G; Kelehan P; Kennedy S; Clynes M
J Clin Pathol; 1997 Jun; 50(6):465-71. PubMed ID: 9378810
[TBL] [Abstract][Full Text] [Related]
20. Differential recognition of mdr1a and mdr1b gene products in multidrug resistant mouse tumour cell lines by different monoclonal antibodies.
Barrand MA; Twentyman PR
Br J Cancer; 1992 Feb; 65(2):239-45. PubMed ID: 1346747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
